表1
对每种阳性结果的流行率进行抗体分析，并与研究组和对照组进行比较。
|
| 抗体 |
积极被试人数 |
优势比(95%置信区间) |
| 研究小组(） |
对照组(） |
|
| 出现抗精子抗体(研究) |
|
|
|
| 血清亚撒 |
5/52 (9.6%) |
1/25 (4.0%) |
2.55 (0.28 - -23.10) |
| 宫颈排卵粘液ASA |
6/52 (11.5%) |
1/25 (4.0%) |
3.13 (0.36 - -27.52) |
| 抗透明带抗体(aZP) |
|
|
|
| aZP免疫球蛋白 |
12/52 (23.0%) |
0/25 (0.0%) |
N/A |
| aZP IgM |
1/52 (1.9%) |
0/25 (0.0%) |
N/A |
| 抗磷脂抗体(aPL)抗 |
|
|
|
| 磷酸盐的酸免疫球蛋白 |
1/52 (1.9%) |
0/25 (0.0%) |
N/A |
| 磷酸盐的酸IgM |
0/52 (0.0%) |
0/25 (0.0%) |
N/A |
| 磷脂酰甘油免疫球蛋白 |
2/52 (3.8%) |
0/25 (0.0%) |
N/A |
| 磷脂酰甘油IgM |
0/52 (0.0%) |
0/25 (0.0%) |
N/A |
| 磷脂酰肌醇免疫球蛋白 |
35/52 (67.3%) |
0/25 (0.0%) |
N/A |
| 磷脂酰肌醇IgM |
2/52 (3.8%) |
1/25 (4.0%) |
0.96 (0.08 - -11.12) |
| 磷脂酰乙醇胺免疫球蛋白 |
16/52 (30.8%) |
0/25 (0.0%) |
N/A |
| 磷脂酰乙醇胺IgM |
3/52 (5.8%) |
1/25 (4.0%) |
1.47 (0.15 - -14.88) |
| 磷脂酰丝氨酸免疫球蛋白 |
32/52 (61.5%) |
0/25 (0.0%) |
N/A |
| 磷脂酰丝氨酸IgM |
2/52 (3.8%) |
2/25 (8.0%) |
0.46 (0.06 - -3.47) |
| 心磷脂免疫球蛋白 |
16/52 (30.8%) |
2/25 (8.0%) |
5.11 (1.07 - -24.33) |
| 心磷脂IgM |
4/52 (7.7%) |
0/25 (0.0%) |
N/A |
| beta-2-glycoprotein免疫球蛋白 |
15/52 (28.8%) |
0/25 (0.0%) |
N/A |
| beta-2-glycoprotein IgA |
9/52 (17.3%) |
0/25 (0.0%) |
N/A |
| annexin-V |
7/52 (13.5%) |
0/25 (0.0%) |
N/A |
|
|
注:有统计意义的值用粗体标注。
|
